Exclusive: Questionable data propped up cancer drug Provenge

Filed under: drug addiction treatment act

The U.S. Food and Drug Administration also stood by its April 2010 decision to approve the treatment. But the disclosure could mark another setback for Dendreon,… Continue reading →